PL348758A1 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents
Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous systemInfo
- Publication number
- PL348758A1 PL348758A1 PL99348758A PL34875899A PL348758A1 PL 348758 A1 PL348758 A1 PL 348758A1 PL 99348758 A PL99348758 A PL 99348758A PL 34875899 A PL34875899 A PL 34875899A PL 348758 A1 PL348758 A1 PL 348758A1
- Authority
- PL
- Poland
- Prior art keywords
- nervous system
- central nervous
- treating diseases
- azabicycloalkane derivatives
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854147A DE19854147A1 (en) | 1998-11-24 | 1998-11-24 | Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative |
| PCT/EP1999/008734 WO2000030639A1 (en) | 1998-11-24 | 1999-11-12 | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348758A1 true PL348758A1 (en) | 2002-06-03 |
Family
ID=7888824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99348758A PL348758A1 (en) | 1998-11-24 | 1999-11-12 | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1133293A1 (en) |
| JP (1) | JP2002530333A (en) |
| KR (1) | KR20010080535A (en) |
| CN (1) | CN1328455A (en) |
| AR (1) | AR021502A1 (en) |
| AU (1) | AU1775300A (en) |
| BG (1) | BG105549A (en) |
| BR (1) | BR9915589A (en) |
| CA (1) | CA2352526A1 (en) |
| CZ (1) | CZ20011796A3 (en) |
| DE (1) | DE19854147A1 (en) |
| HK (1) | HK1040933A1 (en) |
| HR (1) | HRP20010472A2 (en) |
| HU (1) | HUP0104416A3 (en) |
| IL (1) | IL143181A0 (en) |
| NO (1) | NO20012538L (en) |
| PL (1) | PL348758A1 (en) |
| SK (1) | SK7112001A3 (en) |
| TR (1) | TR200101476T2 (en) |
| WO (1) | WO2000030639A1 (en) |
| ZA (1) | ZA200103976B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1836183A2 (en) | 2004-12-13 | 2007-09-26 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
| GB0812310D0 (en) | 2008-07-03 | 2008-08-13 | Syngenta Ltd | Novel herbicides |
| WO2014111837A1 (en) * | 2013-01-15 | 2014-07-24 | Novartis Ag | Use of alpha 7 nicotinic acetylcholine receptor agonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004311A1 (en) * | 1987-11-12 | 1989-05-18 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| DE4427648A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use |
| DE4341403A1 (en) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituted 3-azabicycloalkane derivatives, their preparation and use |
| DE4427647A1 (en) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituted azabicycloheptane derivatives, their preparation and use |
-
1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/en not_active Withdrawn
-
1999
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/en unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/en active Pending
- 1999-11-12 PL PL99348758A patent/PL348758A1/en not_active Application Discontinuation
- 1999-11-12 EP EP99960974A patent/EP1133293A1/en not_active Withdrawn
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/en not_active IP Right Cessation
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/en unknown
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/en unknown
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/en not_active Application Discontinuation
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/en not_active Application Discontinuation
- 1999-11-12 CN CN99813559A patent/CN1328455A/en active Pending
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/en unknown
- 1999-11-12 IL IL14318199A patent/IL143181A0/en unknown
- 1999-11-24 AR ARP990105979A patent/AR021502A1/en unknown
-
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/en not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/en unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/en not_active Application Discontinuation
-
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE19854147A1 (en) | 2000-05-25 |
| BG105549A (en) | 2001-12-29 |
| HUP0104416A2 (en) | 2002-04-29 |
| HUP0104416A3 (en) | 2002-11-28 |
| EP1133293A1 (en) | 2001-09-19 |
| IL143181A0 (en) | 2002-04-21 |
| ZA200103976B (en) | 2002-05-16 |
| CN1328455A (en) | 2001-12-26 |
| NO20012538L (en) | 2001-07-04 |
| HRP20010472A2 (en) | 2003-04-30 |
| AR021502A1 (en) | 2002-07-24 |
| SK7112001A3 (en) | 2001-12-03 |
| NO20012538D0 (en) | 2001-05-23 |
| HK1040933A1 (en) | 2002-06-28 |
| BR9915589A (en) | 2001-08-07 |
| CA2352526A1 (en) | 2000-06-02 |
| TR200101476T2 (en) | 2001-10-22 |
| WO2000030639A1 (en) | 2000-06-02 |
| AU1775300A (en) | 2000-06-13 |
| CZ20011796A3 (en) | 2002-05-15 |
| KR20010080535A (en) | 2001-08-22 |
| JP2002530333A (en) | 2002-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| PL344304A1 (en) | Combination therapy for treatment of bipolar disorders | |
| IL138129A (en) | Composition for therapy of estrogen-associated disorders | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| PL350679A1 (en) | Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders | |
| IL141263A0 (en) | Methods for treatment of neurological disorders | |
| SI0908458T1 (en) | Substituted pyridylmethylpiperazine and piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders | |
| EP1207874A4 (en) | Methods of treating proliferative disorders | |
| AU7788500A (en) | Use of substance p antagonists for influencing the circadian timing system | |
| EE200000391A (en) | Triazine compounds for the treatment of central nervous system disorders | |
| HUP0104701A3 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds | |
| ATE256126T1 (en) | 5-HETEROATOM-ALKYL SUBSTITUTED 3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| HK1038510B (en) | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases | |
| PL348758A1 (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
| HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
| IL135994A0 (en) | Combination therapy for the treatment of aids | |
| IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders | |
| PT1011678E (en) | Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders | |
| GB0010496D0 (en) | Treatment of conditions of the central nervous system | |
| GB9901808D0 (en) | Drugs for treatment of psychiatric and brain disorders | |
| GB9821610D0 (en) | Treatment of neuropsychiatric disorders | |
| GB9923551D0 (en) | Treatment of neuropsychiatric disorders | |
| SI1133290T1 (en) | Use of inhibitors of acetylcholinesterase for the treatment of deliriums | |
| UA25221A (en) | METHOD OF TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |